Skip to main content
OpenTrials

Clinical trial condition

Glycogen Storage Disease

Explore clinical trials studying Glycogen Storage Disease. Study availability and eligibility vary by location and protocol.

129 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Glycogen Storage Disease trial results

Completed

Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease

NCT04120168

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations
  • Adana City Hospital Adana, Turkey (Türkiye)
  • Baskent University Adana Hospital Adana, Turkey (Türkiye)
  • Çukurova University Faculty of Medicine, Pediatric Gastroenterology Adana, Turkey (Türkiye)
  • Afyonkarahisar Health Sciences University Afyonkarahisar, Turkey (Türkiye)
View all 51 locations
View Trial Details
Completed

Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

NCT04574830

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +5 more
Locations
  • University of California Irvine, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • University of Texas Medical School Houston, Texas, United States
View Trial Details
Completed

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

NCT02140151

Conditions
Age-Related Macular Degeneration, Brain Diseases, Brain Diseases, Metabolic, +18 more
Locations
  • Northern California Retina Vitreous Associates Mountain View, California, United States
  • Southern California Desert Retina Consultants Palm Desert, California, United States
  • Elman Retina Baltimore, Maryland, United States
  • Black Hills Regional Eye Institute Rapid City, South Dakota, United States
View Trial Details
Completed

Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease

NCT01410890

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Investigational Site Number 840008 Valhalla, New York, United States
  • Investigational Site Number 840007 Cincinnati, Ohio, United States
  • Investigational Site Number 840005 Salt Lake City, Utah, United States
  • Investigational Site Number 840003 Fairfax, Virginia, United States
View Trial Details

Related conditions